Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks Page 145

Biotech Stocks

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

ME Staff - February 26, 2019

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

novo

The How, What and When of Semaglutide

ME Staff - July 13, 2015 0
Epizyme Celgene

Celgene Sees Opportunity in Epizyme, Should We?

ME Staff - July 13, 2015 0
Gensight

IPO Watch: Novartis Majority Held GenSight; Hit or Miss?

ME Staff - July 9, 2015 0
Novartis

What Entresto Means for Novartis

ME Staff - July 9, 2015 0
Axovant

Is the Axovant IPO a Biotech Red Flag?

ME Staff - July 7, 2015 0
Juno Therapeutics

Celgene Values Juno at Twice Market Rate; Valid Upside Target?

ME Staff - June 30, 2015 0
juno

As Good News Flows Out, Smart Money Flows into Juno Therapeutics

ME Staff - June 26, 2015 0
Tekmira

Tekmira’s Ebola Drug Out Of the Race; Who’s Left in?

ME Staff - June 23, 2015 0
Frost Opko

Opko Shorts Should Know That For Every Short Seller, There’s a...

- June 22, 2015 0
Aerie Pharmaceuticals

Aerie Soars on FDA News: Here’s Why

ME Staff - June 18, 2015 0
1...144145146Page 145 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

May 11, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 27, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 7, 2025

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019